Nautilus Biotechnolgy/$NAUT
About Nautilus Biotechnolgy
Ticker
Industry
Employees
NAUT Metrics
$231M
-
-$0.56
1.03
-
Price and volume
Market cap
$231M
Beta
1.03
52-week high
$3.12
52-week low
$1.61
Average daily volume
164K
Financial strength
Current ratio
16.648
Quick ratio
16.233
Long term debt to equity
12.356
Total debt to equity
14.128
Management effectiveness
Return on assets (TTM)
-17.62%
Return on equity (TTM)
-28.04%
Valuation
Price to book
1.03
Price to tangible book (TTM)
1.03
Price to free cash flow (TTM)
-3.776
Growth
Earnings per share change (TTM)
16.57%
3-year earnings per share growth (CAGR)
-4.14%
What the Analysts think about NAUT
Analyst Ratings
NAUT Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
NAUT Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
NAUT News
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript
FAQs
What’s the current market cap for Nautilus Biotechnolgy stock?
What is the P/E ratio for Nautilus Biotechnolgy stock?
Does Nautilus Biotechnolgy stock pay dividends?
No, Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Nautilus Biotechnolgy dividend payment date?
Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders.
What is the beta indicator for Nautilus Biotechnolgy?
Nautilus Biotechnolgy (NAUT) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.